1 in 3 Covaxin recipients hit by adverse events: Study
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin,..
IndiaTimes
Serum Institute of India
Indian biotechnology and biopharmaceuticals company
Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company, based in Pune. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.
0 shares
2 views